Stock PYXS PYXIS ONCOLOGY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Pyxis Oncology, Inc.

Equities

PYXS

US7473241013

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-24 EDT 		5-day change 1st Jan Change
3.81 USD -0.26% Intraday chart for Pyxis Oncology, Inc. -8.19% +111.67%
05-14 Earnings Flash (PYXS) PYXIS ONCOLOGY Posts Q1 Revenue $16.1M MT
05-14 Pyxis Oncology, Inc. Appoints Stephen Worsley as its Senior Vice President CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
PYXIS ONCOLOGY, INC. Stock Pyxis Oncology, Inc.
 224M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 118B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 23.4B -
ARGENX SE Stock argenx SE
 21.78B -
GENMAB A/S Stock Genmab A/S
 18.09B
  1. Stock Market
  2. Equities
  3. PYXS Stock
  4. Charts Pyxis Oncology, Inc.
  5. Sector Chart